PrimeRFP SCOUT · Federal Contract Recompete Brief

75N92025P00381REVIO SMRT CELLS and sequencing reagents — Pacific Biosciences of California, Inc

Pacific Biosciences of California, Inc holds $7.8M across 81 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. Competition previously drew 2 offers. Set-aside status: NONE. Recompete timing centers on the Sep 26, 2026 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Nhlbi
Awarding office
Pacific Biosciences of California, Inc
Recipient
Sep 26, 2026
PoP end
$198K
Obligated
$198K
Potential
334516
NAICS
6505
PSC
NONE
Set-aside
2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Pacific Biosciences of California, Inc — $90

Contract facts

NONE
Contract number75N92025P00381
AgencyNational Institutes Of Health Nhlbi
Awarding officeNational Institutes Of Health Nhlbi
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentPacific Biosciences of California, Inc
CAGE49H66
UEICP22V46XYQK6
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6505
Place of performanceMENLO PARK CA
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
Related solicitation75N92025Q00129
PoP startSep 16, 2025
PoP end (current)Sep 26, 2026
Obligated$198K
Current value$198K
Potential value$198K

REVIO SMRT CELLS AND SEQUENCING REAGENTS - NEW AWARD is a federal NONE award for National Institutes Of Health Nhlbi held by Pacific Biosciences of California, Inc. Estimated value $198K ($198K obligated). Current period of performance ends Sep 26, 2026. Last award drew 2 bidders. Place of performance: MENLO PARK CA. Related solicitation 75N92025Q00129.

REVIO SMRT CELLS AND SEQUENCING REAGENTS - NEW AWARD

Recompete timing

Public
Expiring in 36 days

Current PoP ends Sep 26, 2026 (36 days remaining). Agencies typically plan 12–18 months ahead — at 1.2 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Pacific Biosciences of California, Inc$7.8M obligated across 81 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($7.8M) · all agencies
Department of Health and Human Services (HHS)$5.3M · 68%Department of Agriculture (USDA)$2.3M · 29%Department of Defense (DOD)$197K · 3%
Open full company profile

Related awards

Same incumbent
1232SA26F0221
LONG-READ SEQUENCING REAGENTS OF WHOLE GENOME ANALYSES
$240K
Sep 30, 2026
1232SA25F0277
PACBIO REAGENT KITS. ALL REAGENTS FOR SEQUENCING 24 REVIO SMRT CELLS QUANTITY 8, AND ASSOC…
$233K
Sep 30, 2026
75F40121P00562
VERSATILE SEQUENCING II SYSTEM
$483K
Nov 16, 2026
75N98026P00928
NHGRI: SUPPLY: SEQUENCING REAGENTS: N/A
$347K
Jul 7, 2027
75F40122C00152
SERVICE CONTRACT FOR A SEQUEL 2E LONG-READ SEQUENCER
$246K
Sep 19, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N92025P00381?

75N92025P00381 (REVIO SMRT CELLS and sequencing reagents) is a National Institutes Of Health Nhlbi award with a potential value of $198K, currently held by Pacific Biosciences of California, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N92025P00381?

National Institutes Of Health Nhlbi awarded 75N92025P00381 to Pacific Biosciences of California, Inc (potential $198K).

Who is the incumbent on 75N92025P00381?

Pacific Biosciences of California, Inc is the incumbent with $7.8M across 81 related awards in SCOUT’s public footprint. The current period of performance ends Sep 26, 2026.

When does Pacific Biosciences of California, Inc’s 75N92025P00381 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 26, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N92025P00381